The 92nd Annual Meeting
of the Japanese Gastric Cancer
Association

Date: March 4(Wed) – March 6(Fri), 2020, Venue: PACIFICO Yokohama, Congress President: Atsushi Ochiai, M.D., Ph.D.(Director of Exploratory Oncology Research & Clinical Trial Center, National Cancer Center)

Call for Abstracts

Abstract Submission Period

Abstract Submission is now closed.
Thank you for your submission.

Abstracts for oral, poster or video presentation

(Thu) 1st August 2019 – (Tue) 17th September 2019
Final deadline has been extended to Noon,(Tue) 24th September 2019
Final deadline has been extended to Noon,(Tue) 1st October 2019
Final deadline has been extended to 17:00, (Tue) 8th October 2019

Presentation Style

Please select one of the presentation styles below:

  • Oral presentation
  • Poster presentation (Time for oral presentation available)
  • Video presentation

    * The detailed information for preparation of the presentation slides and data will be announced after the notification of the acceptance or rejection.

Presentation Categories

Please select the most appropriate category for your presentation.
The Program Committee will make the final decision on the presentation categories.

Symposium / Panel discussion / Workshop / Video Workshop categories

Purpose of application for each session Please refer to the program page for details.

Symposium
  • Beyond the current ESD for gastric tumor
  • Update of peri-operative chemotherapy for gastric cancer
  • Current status of immune checkpoint inhibitors for gastric cancer
  • State of the art of EGJ cancer: diagnosis, endoscopic treatment, and perioperative therapy
  • State of the art of EGJ cancer: surgical procedures
  • Gastric cancer treatment in the world: bridges between East and West
  • Evidences and real world data of gastric cancer surgery: Minimally invasive Surgery
  • Evidences and real world data of gastric cancer surgery: Basics
  • Development of GIST treatment for last two decades and future perspectives
Panel discussion
  • New perspectives of gastric cancer screening
  • Breakthrough treatment for gastric cancer
  • New agents on the horizon in gastric cancer
  • Pros and cons of reconstruction methods after proximal gastrectomy
  • Perspectives of splenic hilar dissection with or without splenectomy in the treatment of proximal advanced gastric cancer
Workshop
  • Novel endoscopic diagnosis for gastric cancer
  • Perspective of newer treatments of schirrus-type gastric cancer or peritoneal dissemination
  • Upcoming biomarkers for gastric cancer
  • Beyond the current gastric surgery:robot, navigation, and sentinel-guided

Oral / Video / Poster Categories

1Epidemiology
2Pathology
3Molecular biology
4Molecular pathology
5Genomics
6Epigenomics
7Development of gastric cancer
8Translational research
9H.pylori
10Progression of gastric cancer
11Rare metastasis / Micrometastasis
12Intraoperative frozen section
13Cancer stem cell
14Gastric cancer screening
15Precision medicine
16Endoscopic diagnosis
17IEE
18Endoscopic therapy
19Imaging diagnosis
20AI
21Clinical study
22Chemotherapy
23Neoadjuvant chemotherapy
24Adjuvant chemotherapy
25Second-line chemotherapy
26Intraperitoneal chemotherapy
27Molecular targeted therapy
28Biomarker
29Immunotherapy
30Radiation therapy
31Chemoradiotherapy
32Conversion surgery
33Surgery
34Laparoscopic surgery
35Robot surgery
36Function-preserving surgery
37Cytoreductive surgery
38LECS
39Surgical navigation
40Postoperative functional assessment
41Postgastrectomy syndrome
42Perioperative management
43Postoperative complications
44ERAS
45Sentinel lymph node
46Peritoneal dissemination
47CART
48Stent placement
49Liver metastasis
50Recurrence
51Early gastric cancer
52Advanced gastric cancer
53Scirrhous gastric cancer
54Gastric stump carcinoma
55Multiple gastric cancers
56Gastric tube cancer
57Gastric cardia cancer
58Esophago-gastric junction cancer
59Gastric cancer in elderly patients
60AFP-producing gastric cancer
61EBV-related gastric cancer
62Gastrointestinal stromal tumor
63Malignant lymphoma
64Gastric neuroendocrine tumor
65Fundic gland type gastric cancer
66Guidelines
67Clinical pathway
68Postoperative surveillance
69Long-term survival case after chemotherapy
70Outcome
71Prognostic factor
72QOL assessment
73Cachexia
74Nutrition
75Obesity
76Case report
77Japanese Classification of Gastric Carcinoma
78Multidisciplinary treatment
79Palliative therapy
80Team approach
81MDT conference
82Medical cooperation
83Oral care
84Others

Abstract Acceptance or Rejection

Please note that the decision on abstract acceptance/rejection and presentation style (oral, poster or video) is left to the sole discretion of the Congress President.

Abstract Submission

Language for abstract

English

Language for presentation

English

Language for presentation slides

English

The number of characters

Title: up to 100 characters (including spaces)
Abstract: up to 1600 characters (including spaces)

Travel Grants

We invite you to submit applications for travel grants with details as below. Please apply by selecting "Apply" at the time of abstract submission.

  1. Applicant's eligibility
    • The applicant must be aged 40 or under at the time of abstract submission.
    • The applicant must be working or training in a country other than Japan.
    • The applicant may submit only one abstract.
  2. The presentation must be given and slides must be prepared in English.
  3. The travel grant of ¥100,000 will be awarded and participation will be free of charge. The applicant must arrange, however, transportation, accommodation, etc. on his/her own.
  4. The Congress President reserves the right of acceptance or rejection for all submitted presentations.
  5. It is the applicant's own responsibility to obtain the proper visa to enter Japan.
  6. Applicants will individually be notified of travel grant decisions by December 2019.

Conflict of Interest Disclosure

The author is required to report applicable COI (Conflict of Interest) by completing the "Conflict of Interest Disclosure" part in the Abstract Submission process.

  • If there is no COI to disclose
  • If there is any COI to disclose

Submission Page

  • Go to Abstract Submission page

Inquiries

Secretariat of 92nd Annual Meeting of The Japanese Gastric Cancer Association
c/o Japan Convention Services, Inc.
14F Daido Seimei Kasumigaseki Bldg.
1-4-2, Kasumigaseki, Chiyoda-ku,
Tokyo 100-0013, Japan
Tel: +81-3-3500-5935 (Open hours 9:30 - 17:30)
E-mail: endai-92jgca[A]convention[D]co[D]jp (Please change [A] to @,[D] to .)

Congress Secretariat

Japan Convention Services, Inc.
14F. Daido Seimei Kasumigaseki Bldg., 1-4-2 Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan
Tel: +81-3-3508-1214
Fax: +81-3-3508-1302
E-mail: 92jgca[A]convention[D]co[D]jp(Please change [A] to @,[D] to .)

page-top